1. Home
  2. RPRX vs ITT Comparison

RPRX vs ITT Comparison

Compare RPRX & ITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • ITT
  • Stock Information
  • Founded
  • RPRX 1996
  • ITT 1920
  • Country
  • RPRX United States
  • ITT United States
  • Employees
  • RPRX N/A
  • ITT N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • ITT Fluid Controls
  • Sector
  • RPRX Health Care
  • ITT Industrials
  • Exchange
  • RPRX Nasdaq
  • ITT Nasdaq
  • Market Cap
  • RPRX 16.2B
  • ITT 14.1B
  • IPO Year
  • RPRX 2020
  • ITT N/A
  • Fundamental
  • Price
  • RPRX $39.71
  • ITT $184.69
  • Analyst Decision
  • RPRX Strong Buy
  • ITT Strong Buy
  • Analyst Count
  • RPRX 3
  • ITT 10
  • Target Price
  • RPRX $46.00
  • ITT $201.11
  • AVG Volume (30 Days)
  • RPRX 4.5M
  • ITT 517.9K
  • Earning Date
  • RPRX 11-05-2025
  • ITT 10-29-2025
  • Dividend Yield
  • RPRX 2.21%
  • ITT 0.77%
  • EPS Growth
  • RPRX N/A
  • ITT 2.16
  • EPS
  • RPRX 1.75
  • ITT 5.99
  • Revenue
  • RPRX $2,349,844,000.00
  • ITT $3,813,500,000.00
  • Revenue This Year
  • RPRX $36.16
  • ITT $7.64
  • Revenue Next Year
  • RPRX $2.04
  • ITT $5.60
  • P/E Ratio
  • RPRX $22.74
  • ITT $30.63
  • Revenue Growth
  • RPRX 3.70
  • ITT 8.01
  • 52 Week Low
  • RPRX $24.05
  • ITT $105.64
  • 52 Week High
  • RPRX $41.24
  • ITT $197.07
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 59.32
  • ITT 54.20
  • Support Level
  • RPRX $37.31
  • ITT $176.48
  • Resistance Level
  • RPRX $40.00
  • ITT $187.35
  • Average True Range (ATR)
  • RPRX 1.03
  • ITT 4.97
  • MACD
  • RPRX -0.03
  • ITT -0.66
  • Stochastic Oscillator
  • RPRX 85.66
  • ITT 50.71

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About ITT ITT Inc.

ITT began its journey as International Telephone & Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.

Share on Social Networks: